ArticleKidney international reports2025
Single-Nucleus RNA-Sequencing Identifies a Differential Profibrotic Response in Parietal Epithelial Cells in Primary Versus Maladaptive Focal Segmental Glomerulosclerosis.
Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Focal segmental glomerulosclerosis (FSGS) lesions occur in a wide range of clinical conditions that are all characterized by critical podocyte injury. Differentiating primary from maladaptive forms of FSGS remains challenging because of the absence of reliable biomarkers, resulting from a lack of insight into their pathophysiological differences. Methods: We used single-nucleus RNA-sequencing (snRNA-seq) to identify differentially expressed transcriptional signatures in kidney biopsies of well-phenotyped primary versus maladaptive FSGS. We included cryopreserved kidney biopsy cores from adult patients with newly diagnosed primary FSGS ( Results: We identified 120,751 high-quality nuclei, including 2471 podocytes and 1574 parietal epithelial cells (PECs). In primary FSGS, podocytes showed a more pronounced but not specific injury pattern with upregulation of immune pathways, such as antigen presentation, and mammalian target of rapamycin (mTOR) complex 1 (mTORC1)-signaling. Glomerular cell-cell interaction analysis showed increased profibrotic TGF-β and PDGFR-β signaling in primary FSGS PECs, which also upregulated genes that compose the normal PEC-derived extracellular matrix (ECM) ( Conclusion: This study presents a single-cell transcriptional landscape of well-phenotyped patients with FSGS and provides evidence for a differential profibrotic PEC response in primary versus maladaptive FSGS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.